Insulin glargine: the first clinically useful extended-action insulin analogue

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.2, Iss.11, 2001-11, pp. : 1891-1902

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Insulin glargine: the first clinically useful extended-acting insulin in half a century?

By Home P.

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 3, 1999-03 ,pp. : 307-314

Informa Healthcare

Access to resources Recommend Favorite

Insulin Glargine

By Gillies P.S. Figgitt D.P. Lamb H.M.

Drugs, Vol. 59, Iss. 2, 2000-02 ,pp. : 253-260

Adis International

Access to resources Recommend Favorite

A combination of insulin glargine and rapid-acting insulin analogue (RAIA) is effective for the treatment of children with type 1 diabetes.

Inpharma, Vol. 1, Iss. 1636, 2008-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Insulin glargine: timing not an issue

Inpharma, Vol. 1, Iss. 1397, 2003-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Insulin glargine dually compared

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 591, 2009-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite